A groundbreaking investigation by Cedars-Sinai researchers has illuminated a previously unrecognized biological mechanism that holds significant promise for the development of novel therapeutic strategies targeting spinal cord injuries, strokes, and neurodegenerative conditions such as multiple sclerosis. The study, detailed in the esteemed journal Nature, reveals an unanticipated but crucial function for astrocytes, a predominant category of glial cells integral to the central nervous system’s support structure. These findings shift the paradigm of our understanding regarding the body’s inherent capacity for neurological repair, suggesting that cells far removed from the initial site of damage play an active and vital role in initiating the healing cascade.
Neuroscientist Joshua Burda, PhD, an assistant professor of Biomedical Sciences and Neurology at Cedars-Sinai and the senior author of this pivotal research, emphasized the fundamental importance of astrocytes in responding to ailments affecting the brain and spinal cord. "Astrocytes are critical responders to disease and disorders of the central nervous system — the brain and spinal cord," Dr. Burda stated. "We discovered that astrocytes far from the site of an injury actually help drive spinal cord repair. Our research also uncovered a mechanism used by these unique astrocytes to signal the immune system to clean up debris resulting from the injury, which is a critical step in the tissue-healing process." This discovery challenges the long-held assumption that repair mechanisms are solely localized to the immediate vicinity of an injury.
The researchers have designated these pivotal cells as "lesion-remote astrocytes," or LRAs, and have further categorized them into distinct subtypes, each exhibiting unique capabilities. For the first time, this research provides a detailed explanation of how a specific LRA subtype can sense damage occurring at a considerable distance and subsequently orchestrate a restorative response that fosters recovery. This sophisticated communication network underscores the intricate and interconnected nature of the central nervous system.
To fully appreciate the significance of LRAs, it is essential to understand the spinal cord’s response to trauma. The spinal cord, a complex conduit of neural tissue extending from the brain, comprises an inner core of gray matter, housing nerve cell bodies and astrocytes, and an outer region of white matter, composed of astrocytes and extensive nerve fibers responsible for transmitting signals throughout the body. Astrocytes in these regions are primarily tasked with maintaining a stable microenvironment, ensuring the efficient and unimpeded propagation of neural signals.
Upon sustaining an injury, such as a traumatic impact or a severe lesion, the delicate nerve fibers within the spinal cord are severed. This physical disruption can lead to profound functional deficits, including paralysis and the loss of sensory perception, affecting sensations like touch and temperature. The resulting fragmentation of nerve fibers generates cellular debris. In most bodily tissues, the inflammatory response to damage is typically contained within the injured zone. However, the elongated architecture of the spinal cord means that damaged fibers and the associated inflammatory cascade can extend far beyond the initial site of injury, complicating the healing process and potentially causing secondary damage.
The Cedars-Sinai study’s experimental models, utilizing mice subjected to spinal cord injuries, provided compelling evidence for the critical role of LRAs in promoting repair. The researchers observed that these distant astrocytes actively contribute to the healing process, and importantly, they found corroborating evidence in spinal cord tissue samples from human patients, suggesting the universality of this repair pathway across species.
A key finding involves a specific subtype of LRA that produces a protein known as CCN1. This molecule acts as a sophisticated signaling agent, communicating directly with immune cells called microglia. Microglia are the resident phagocytic cells of the central nervous system, analogous to "garbage collectors" tasked with clearing cellular waste and debris. "One function of microglia is to serve as chief garbage collectors in the central nervous system," Dr. Burda explained. "After tissue damage, they eat up pieces of nerve fiber debris — which are very fatty and can cause them to get a kind of indigestion. Our experiments showed that astrocyte CCN1 signals the microglia to change their metabolism so they can better digest all that fat." This metabolic recalibration is crucial, as the accumulation of undigested fatty debris can exacerbate inflammation and hinder tissue regeneration.
Dr. Burda further elaborated on the implications of this enhanced debris clearance, suggesting it could contribute to the partial, spontaneous recovery observed in some individuals following spinal cord injury. Conversely, when the researchers experimentally inhibited the production of astrocyte-derived CCN1, the healing process was significantly impaired. "If we remove astrocyte CCN1, the microglia eat, but they don’t digest. They call in more microglia, which also eat but don’t digest," Dr. Burda noted. "Big clusters of debris-filled microglia form, heightening inflammation up and down the spinal cord. And when that happens, the tissue doesn’t repair as well." This demonstrates a delicate balance where effective waste management by the immune system, orchestrated by LRAs, is essential for optimal tissue repair and functional recovery.
The implications of these findings extend beyond spinal cord injuries, offering new perspectives on other neurological conditions. When the research team analyzed spinal cord samples from individuals diagnosed with multiple sclerosis, they observed the same CCN1-mediated repair process at play. This suggests that the fundamental principles governing LRA function and their interaction with the immune system may be broadly applicable to a range of injuries and diseases affecting both the brain and the spinal cord.
David Underhill, PhD, chair of the Department of Biomedical Sciences at Cedars-Sinai, highlighted the underappreciated role of astrocytes in neurological healing. "The role of astrocytes in central nervous system healing is remarkably understudied," Dr. Underhill remarked. "This work strongly suggests that lesion-remote astrocytes offer a viable path for limiting chronic inflammation, enhancing functionally meaningful regeneration, and promoting neurological recovery after brain and spinal cord injury and in disease." His statement underscores the transformative potential of this research in shaping future therapeutic interventions.
Building upon these foundational discoveries, Dr. Burda is actively pursuing the development of therapeutic strategies designed to leverage the CCN1 pathway to improve outcomes for spinal cord injury patients. Furthermore, his team is investigating the potential influence of astrocyte CCN1 on inflammatory neurodegenerative diseases and the aging process, opening avenues for broader applications in neurological health. The study also acknowledges the collaborative efforts of numerous Cedars-Sinai authors, including Sarah McCallum, Keshav B. Suresh, Timothy S. Islam, Manish K. Tripathi, Ann W. Saustad, Oksana Shelest, Aditya Patil, David Lee, Brandon Kwon, Katherine Leitholf, Inga Yenokian, Sophia E. Shaka, Jasmine Plummer, Vinicius F. Calsavara, and Simon R.V. Knott, as well as external collaborators Connor H. Beveridge, Palak Manchandra, Caitlin E. Randolph, Gordon P. Meares, Ranjan Dutta, Riki Kawaguchi, and Gaurav Chopra, whose contributions were instrumental to the study’s success. The research was made possible through substantial funding from various national and international sources, including the US National Institutes of Health (NIH) with multiple grant numbers, the Paralyzed Veterans Research Foundation of America, Wings for Life, the Cedars-Sinai Center for Neuroscience and Medicine, the American Academy of Neurology, the California Institute for Regenerative Medicine, the United States Department of Defense USAMRAA, and the Arnold O. Beckman Postdoctoral Fellowship, alongside support from the Purdue University Center for Cancer Research.
About the Author
